Anhui Biochem Pharmaceutical Co., Ltd, established in 2007, is a high-tech enterprise specializing in the research, production, and marketing of anti-HIV and anti-HBV chiral drugs. The company was formed through a collaboration between Anhui Biochem Pharmaceutical, established in 2003, and QVT Fund. The company has over 400 staff members and focuses on the development and production of antiviral drugs. With a total asset of over RMB 510 million and covering an area of 50.74 acres, the company serves various markets including Africa, Central America, East Asia, the Middle East, South America, South Asia, and Southeast Asia.